YI Insider Trading
Insider Ownership Percentage: 43.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $141,105.40
111 Share Price & Price History
Current Price: $3.80
Price Change: ▼ Price Decrease of -0.4 (-9.52%)
As of 07/13/2026 03:59 PM ET
111 Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 6/15/2026 | Jian David Sun | Director | Sell | 58,800 | $0.23 | $13,524.00 | 413,211 |  |
| 6/15/2026 | Yang Luke Chen | Director | Sell | 44,000 | $0.23 | $10,120.00 | 495,462 | |
| 6/12/2026 | Yang Luke Chen | Director | Sell | 49,920 | $0.23 | $11,481.60 | 539,462 | |
| 6/11/2026 | Jian David Sun | Director | Sell | 111,100 | $0.23 | $25,553.00 | 472,011 | |
| 6/10/2026 | Jian David Sun | Director | Sell | 115,440 | $0.22 | $25,396.80 | 583,111 | |
| 6/9/2026 | Jian David Sun | Director | Sell | 12,000 | $0.23 | $2,760.00 | 698,551 | |
| 5/27/2026 | Jian David Sun | Director | Sell | 70,440 | $0.25 | $17,610.00 | 710,551 | |
| 5/27/2026 | Jun Justin Luo | Director | Sell | 70,440 | $0.25 | $17,610.00 | 710,551 | |
| 5/27/2026 | Yang Luke Chen | Director | Sell | 3,400 | $0.25 | $850.00 | 589,382 | |
| 5/26/2026 | Jian David Sun | Director | Sell | 29,280 | $0.27 | $7,905.60 | 780,991 | |
| 5/26/2026 | Jun Justin Luo | Director | Sell | 29,280 | $0.27 | $7,905.60 | 780,991 | |
| 5/26/2026 | Yang Luke Chen | Director | Sell | 1,440 | $0.27 | $388.80 | 592,782 | |
111 Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 5/12/2025 | Connor Clark & Lunn Investment Management Ltd. | 11,338 | $92K | 0.0% | N/A | 0.133% |  |
| 5/8/2025 | Deuterium Capital Management LLC | 10,000 | $81K | 0.2% | N/A | 0.117% | |
| 2/13/2025 | FIL Ltd | 680,799 | $0.45M | 0.0% | N/A | 7.963% | |
| 2/12/2025 | JPMorgan Chase & Co. | 306,039 | $0.19M | 0.0% | +43,619.9% | 3.579% | |
| 2/11/2025 | Napean Trading & Investment Co Singapore PTE Ltd | 393,161 | $0.25M | 0.1% | N/A | 4.598% | |
| 5/7/2024 | Deuterium Capital Management LLC | 100,000 | $0.12M | 0.2% | N/A | 0.120% | |
| 2/13/2024 | Tower Research Capital LLC TRC | 18,558 | $29K | 0.0% | N/A | 0.022% | |
| 6/1/2023 | Prelude Capital Management LLC | 47,000 | $0.13M | 0.0% | +80.8% | 0.000% | |
| 5/10/2023 | Connor Clark & Lunn Investment Management Ltd. | 29,116 | $77K | 0.0% | N/A | 0.000% | |
| 2/14/2023 | Susquehanna International Group LLP | 15,306 | $46K | 0.0% | -51.1% | 0.000% | |
| 2/10/2023 | Greenwoods Asset Management Hong Kong Ltd. | 348,863 | $1.05M | 0.1% | -58.3% | 0.000% | |
| 11/16/2022 | Maven Securities LTD | 28,000 | $75K | 0.0% | N/A | 0.034% | |
| 11/14/2022 | Maven Securities LTD | 28,000 | $75K | 0.0% | N/A | 0.034% | |
| 11/7/2022 | Virtu Financial LLC | 33,034 | $89K | 0.0% | -42.6% | 0.040% | |
| 8/13/2022 | Virtu Financial LLC | 57,507 | $0.12M | 0.0% | N/A | 0.070% | |
Data available starting January 2016
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
Read More on 111
Volume
4,941 shs
Average Volume
33,956 shs
Market Capitalization
$33.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.63
Who are the company insiders with the largest holdings of 111?
